More Women are Dying from Cervical Cancer Since the Gardasil Vaccine Was Introduced by Brian Shilhavy, Editor, Health Impact News
Prior to the COVID-19 experimental vaccines that were tested on the public with disastrous results, the HPV Gardasil vaccine was the #1 most-read topic on Health Impact News, as we have published literally hundreds of articles on this deadly vaccine that has destroyed so many lives.
The Gardasil vaccine produced by Merck is advertised as a way to prevent cervical cancer by stopping the Human papillomavirus. The HPV vaccine causes autoimmune diseases as well as Primary Ovarian Failure making young girls infertile.
And now, a new study from researchers at UCLA has revealed that late stage cervical cancer has actually been increasing since the Gardasil vaccine was launched.
Now is your chance to support Gospel News Network.
We love helping others and believe that’s one of the reasons we are chosen as Ambassadors of the Kingdom, to serve God’s children. We look to the Greatest Commandment as our Powering force.
It seems like a contradiction when it comes to cervical cancer…the September International Journal of Gynecological Cancer shows overall rates are on the decline, but more women are getting diagnoses with stage four cancer. That means more women are dying. (Source.)
Of course if you read about this study in the corporate media, they will interview doctors who recommend more HPV vaccines.
Here is a 2-minute report on this new study out of UCLA from Dr. Peterson Pierre with America’s Frontline Doctors. This is on our Bitchute channel.
The Gardasil Vaccine’s Troubled Past and CDC Corruption
Julie Gerberding was in charge of the CDC from 2002 to 2009, which includes the years the FDA approved the Merck Gardasil vaccine.
Soon after she took over the CDC, she reportedly completely overhauled the agency’s organizational structure, and many of the CDC’s senior scientists and leaders either left or announced plans to leave. Some have claimed that almost all of the replacements Julie Gerberding appointed had ties to the vaccine industry.
Gerberding resigned from the CDC on January 20, 2009, and took over as the president of Merck’s Vaccine division, a 5 billion-dollar-a-year operation, and the supplier of the largest number of vaccines the CDC recommends (article here).
It was reported in 2015 that Dr. Gerberding, now the executive vice president of pharmaceutical giant, Merck, sold 38,368 of her shares in Merck stock for $2,340,064.32. She still holds 31,985 shares of the company’s stock, valued at about $2 million.
